Last reviewed · How we verify
NCT05991960
Evaluation of Real-World Data on the Performance of the TECNIS Odyssey™ IOL
trial testing Intervention in Cataracts in 96 participants. Completed in 4 December 2023.
4 December 2023
Quick facts
| Lead sponsor | Johnson & Johnson Surgical Vision, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 96 |
| Start date | 11 September 2023 |
| Primary completion | 4 December 2023 |
| Estimated completion | 4 December 2023 |
| Sites | 12 locations across United States |
Drugs / interventions tested
- Intervention
Conditions studied
- Cataracts — all drugs for Cataracts →
Sponsor
Johnson & Johnson Surgical Vision, Inc. — full company profile →
Who can join
Eligibility, any sex, with Cataracts. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Retrospective collection of data from medical records, multicenter, post-market clinical follow-up study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05991960
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intervention
Trials testing the same drug.
- NCT07038317 — A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status · NA · not yet recruiting
- NCT06112431 — Eye Health Intervention Study in Upper Manhattan · NA · not yet recruiting
- NCT07202390 — Intraarticular Gold Microparticles for Knee Osteoarthritis · NA · not yet recruiting
- NCT07444736 — Effect of 8 Weeks of Resistance Training With Blood Flow Restriction on Muscle Strength, Clinical Parameters, Biochemica · NA · enrolling by invitation
- NCT07376668 — Effects of a WhatsApp-assisted Prehabilitation for Patient Undergoing Elective Colorectal Cancer Surgery · NA · not yet recruiting
Other Johnson & Johnson Surgical Vision, Inc. trials
Trials by the same sponsor.
- NCT07324200 — Objective Assessment of Intraocular Lens Tilt and Decentration · recruiting
- NCT07218419 — Comparison of Methods for Assessing Intraocular Lens Position · completed
- NCT06797856 — Measurement of Refractive Error in Pseudophakic Eyes Using an Autorefractor and a Wavefront Aberrometer · completed
- NCT05090787 — Clinical Investigation of the TECNIS 1-Piece Intraocular Lens · NA · withdrawn
- NCT06767319 — Prospective, Multi-center, Non-interventional, Open Label, Randomized (Depth of Focus Testing Sequences), Clinical Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05991960 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Surgical Vision, Inc.
- Last refreshed: 2 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05991960.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing